Scott Kellen

Scott Kellen

Chief Financial Officer and SecretaryatDiaMedica Therapeutics· In proxies 2022–2025

Pay in FY2025+51% from the year before · DiaMedica Therapeutics stock +46.6% the same year

Scott Kellen was paid $1.2M in FY2025 (Dec), up 51%. DiaMedica Therapeutics stock rose 46.6% that year.

Pay$100 in the stock at the end of FY21 → $213
Pay is from the Summary Compensation Table of each DiaMedica Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. DiaMedica TherapeuticsPublic company · 4 yr
    • Chief Financial Officer and Secretary2022 – Present · 4 yrStock in role +186%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?